Brucellosis Vaccines Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Market Overview

The brucellosis vaccine market is projected to register a CAGR of 6.2% during the forecast period (2022-2027).

The emergence of the COVID-19 pandemic had an adverse effect on the world economy and the healthcare system. The lockdown all over the globe has affected the supply chain of pharmaceuticals, medical devices, and biotechnological products both for humans and animals. Additionally, during the COVID-19 pandemic, most countries and their states treat pet care/animal care as an essential service. Furthermore, the guidelines were issued by the animal health authorities of various nations to take care of the animal during pandemics at home/farms. For Instance, In April 2020, the Indian Veterinary Research Institute, Izatnagar issued an article titled "Advisory for Livestock Owners during COVID 19 Lockdown," which includes guidelines for do's and don'ts for fractures, wounds, sprains, and other diseases and primary treatment with various therapies. Such issuance of guidelines for different therapy like cold therapies for pain involving treatment of pain with home remedies has also impacted the market's growth over the forecast. Thus, due to the factors mentioned above, COVID-19 has initially impacted the market's growth due to the lockdown and impact on the supply chains. However, animal health is later declared an " essential service" in various nations. Hence, the market is likely to grow in the upcoming period.

Brucellosis is one of the most widespread zoonoses transmitted by animals, and in endemic areas, human brucellosis has serious public health consequences. Expansion of animal industries and urbanization, and the lack of hygienic measures in animal husbandry and food handling, partly account for brucellosis remaining a public health hazard. In June 2019, a report published by CDC titled "Travel-Related Infectious Diseases" stated that more than 500,000 new human cases of brucellosis are reported worldwide each year. However, this number is likely underestimated as brucellosis cases are underreported and often misdiagnosed because symptoms are nonspecific, physicians may lack awareness, and laboratory capacity for diagnosis is limited. B. melitensis is the most frequently reported cause of human illness worldwide, while the most widespread potential source of infection is B. abortus. Hence, increasing the prevalence of the disease would increase the demand for a vaccine which would increase the market growth in the upcoming period. The various initiatives the government and non-government organizations take to raise awareness about animal diseases, health, and protection propel the growth of the studied market over the forecast period. The government of different nations is introducing plans and guidelines for animal welfare. For Instance, in May 2021, United Kingdom Government introduced the first-ever action plan to improve the welfare and conservation of animals at home and abroad. The action plans include improvement and welfare programs for all animals, like incentivizing farmers to improve animal health and welfare through future farming policy. Such initiatives raise awareness about animal health and thus boost the market's growth. Furthermore, In Australia, the Animal Welfare Task Group developed animal welfare standards and guidelines for cattle and sheep. The national livestock identification system (NLIS), an electronic identification system in which each animal is tagged with a radiofrequency identification device, has been developed for cattle. Also, in September 2020, the International animal welfare organization World Animal Protection, along with National Disaster Response Force (NDRF) and other organizations and local communities, organized mobile veterinary treatment camps for animals affected by the floods in Assam. Thus, the studied market is expected to project growth over the forecast period due to the abovementioned factors.

However, stringent regulation for animal vaccines is likely to hinder market growth.

Scope of the Report

As per the scope, brucellosis is a bacterial disease caused by various Brucella species, mainly infecting cattle, swine, goats, sheep, and dogs. Humans acquire the disease through direct contact with infected animals, eating or drinking contaminated animal products, or inhaling airborne agents. The Brucellosis Vaccines Market is Segmented By Vaccine Type (DNA Vaccine, Subunit Vaccine, Vector Vaccine, and Recombinant Vaccine), Application (Cattle, Sheep & Goat, and Others), End User (Veterinary Hospitals & Clinics, Animal Care Centers, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The report offers the value (USD million) for the above segments.

Report scope can be customized per your requirements. Click here.

Key Market Trends

Cattles Expected to Hold a Significant Market Share Over the Forecast Period

Factors such as increasing cattle population and key developments like acquisitions by market players are expected to increase the market growth. According to the United States Department of Agriculture 2020, the world cattle inventory in 2020 was reported at 987.5 million. India has the largest cattle inventory in the world in 2020, followed by Brazil & the United States. Roughly 65% of the world’s cattle are in India, Brazil & the United States. According to the 20th Livestock Census published by the Department of Animal Husbandry & Dairying under the Ministry of Fisheries, Animal Husbandry & Dairying, the total Cattle Population in India was 192.49 Million in 2019. Total cattle increased by 0.8% over the previous livestock census (2012).

Furthermore, increasing activities by key market players are another factor for the segment's growth. For instance, in September 2020, Hester Biosciences Limited signed an agreement with the Indian Council of Agriculture Research (ICAR) and the Indian Veterinary Research Institute (IVRI) to acquire the indigenously developed technology for developing the Brucella Abortus S19 Delta Per vaccine. Hester is currently manufacturing the conventional Brucella Abortus S19 vaccine and supplies it to all States. The S19 Delta Per new generation vaccine technology developed by IVRI will be a step towards developing a Brucella vaccine. The Centre has planned to immunize four crore female calves in India in the first phase against Brucella through vaccination. Hence, such initiatives would increase market growth in the upcoming period.

To understand key trends, Download Sample Report